Stockreport

CorMedix (CRMD): Assessing Valuation After a Strong Multi-Year Share Price Run [Yahoo! Finance]

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF This performance has put fresh attention on this kidney infection focused biotech. See our latest analysis for CorMedix. With the share price now at $12.19 and a 30 [Read more]